A trial looking at a lower dose of chemoradiotherapy for anal cancer that hasn’t spread (PLATO ACT4)

Overview

Cancer types:

Anal cancer

Status:

Results

Phase:

Phase 2

Details

This trial compared standard dose with a lower dose of chemoradiotherapy for anal cancer that hadn’t spread. It was for people with squamous cell carcinoma, the most common type of anal cancer.

The trial was supported by Cancer Research UK. It was open for people to join between 2017 and 2020. The team presented the results at a conference in 2023.

Recruitment start: 13 January 2017

Recruitment end: 1 December 2020

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor David Sebag-Montefiore Dr Mark Harrison Professor Richard Adams

Supported by

Cancer Research UK

Stand Up To Cancer

University of Leeds

Other information

This is Cancer Research UK trial number CRUK/15/007.

Last reviewed: 23 August 2023

CRUK internal database number: 14591

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.